Colorado Attorney General Phil Weiser (D), who defeated Sen. Michael Bennett (D) in Colorado’s Democratic gubernatorial primary, said he would confront congressional candidate Melat Kiros (D) for refusing to condemn the deadly 2025 firebomb attack on Jewish activists in Boulder as antisemitic. Kiros, a democratic socialist and former attorney, scored an upset against incumbent Rep. Diana DeGette...
Former special counsel Jack Smith warned that the U.S. is facing an “attack on the rule of law” under President Trump, saying he is “very concerned” about the integrity of future elections and accusing the administration of weaponizing the Justice Department. Smith, the special counsel who brought charges against Trump following his first term, argued that...
Entry to the National Mall for a record-breaking fireworks show celebrating July 4 has been delayed as Washington, D.C. braces for extreme heat, Freedom 250 organizers said Thursday. President Trump insisted he would still deliver a lengthy speech at Saturday’s “Salute to America 250 Celebration & Fireworks” event, despite forecasts that temperatures will climb to 107 degrees....
Hannah Pingree (D) and Bobby Charles (R) are projected to face off this November in the contested race to succeed retiring Gov. Janet Mills (D), according to Decision Desk HQ. A total of five Democrats and eight Republicans ran for their party's respective nominations for Maine governor. Pingree, the daughter of Rep. Chellie Pingree (D-Maine), is...
A state judge opened the door for Missourians to access medication abortion in a Thursday ruling that comes over a year after state residents voted to legalize abortion access. Missouri circuit judge Jerri Zhang sided with Planned Parenthood in its lawsuit challenging the state’s 30 statutes limiting abortion access. The organization sued the state a...
Vice President Vance’s trip to Switzerland for technical talks on the Iran deal has been postponed, the White House confirmed on Thursday. There were talks the top U.S. official would depart for Europe on Thursday evening for a new round of technical discussions building on an agreement signed by President Trump on Wednesday. Vance told...
The special election for former California Rep. Eric Swalwell’s (D) House seat is headed to a runoff, after no candidate in the race received a majority of the vote, DDHQ projected on Thursday evening. California state Sen. Aisha Wahab (D) and Bay Area transportation official Melissa Hernandez (D) — the race’s top two candidates —...
Sen. Tammy Duckworth (D-Ill.) urged the Federal Aviation Administration (FAA) on Thursday to reject the White House’s plans to erect a triumphal arch near the Lincoln Memorial. The ranking member of the Senate Commerce, Science and Transportation Subcommittee on Aviation called the arch President Trump’s "newest vanity project” in her letter to the federal agency and expressed...
Presented by Planned Parenthood {beacon} Healthcare Health Care PRESENTED BY The Big Story FDA panel gives nod to Moderna flu shot The FDA’s independent vaccine advisors voted unanimously 9-0 that the benefits outweigh the risks for Moderna’s mFlusiva shot in people ages 50 to 64 as well as 65 and older. The shot is...
Presented by Philip Morris International {beacon} Technology Technology PRESENTED BY The Big Story GOP embraces speculation about China’s role in data center backlash Republicans are embracing allegations that data center opposition in the U.S. is being fueled by foreign actors, raising questions over how influence operators are contributing to one of the fiercest debates in...
Vice President Vance was once again thrust to the fore in trying to calm GOP unease over the interim deal between Iran and the U.S. on Thursday. It’s no easy task. Several Republican lawmakers and a larger number of prominent conservative commentators are criticizing the deal. Their complaints vary in the specifics, but the common theme...
A first-of-its-kind flu shot is one step closer to being available to the public after a Food and Drug Administration (FDA) advisory panel voted Thursday to recommend Moderna’s mRNA-based vaccine for approval. The FDA’s independent vaccine advisors voted unanimously 9-0 that the benefits outweigh the risks for Moderna’s mFlusiva shot in people ages 50 to 64 as well as 65 and older. Moderna is...
